Cannabis News
Market-moving headlines, earnings, and regulatory shifts across the cannabis sector
Track the developments that move cannabis stocks — from quarterly earnings and M&A deals to state-level legalization votes and federal policy changes. Articles are tagged with relevant stock tickers so you can see which companies are affected and jump straight to their market data.
Psychedelics Emerge as Next Investment Frontier Beyond Cannabis
Investors pivot to psychedelics sector as cannabis market matures, seeking growth in emerging therapeutic applications and regulatory momentum.
SMG Q2 Earnings: Hawthorne Segment Drags Down Cannabis Exposure
Scotts Miracle-Gro reports mixed Q2 results as cannabis-focused Hawthorne division continues underperforming amid industry headwinds and regulatory uncertainty.
Medical Device Giant Eyes Cannabis Tech as Sector Matures
GE HealthCare's earnings spotlight growing interest from Fortune 500 companies in cannabis testing and cultivation technology as federal barriers ease.
Scotts Miracle-Gro Q2 Earnings Signal Cannabis Pivot Challenges
SMG's second quarter results reveal ongoing struggles in cannabis segment as company navigates market headwinds and operational shifts.
Jazz Pharmaceuticals Breaks Above 52-Week High at $201.03
JAZZ surges past its previous 52-week high of $198.00, trading at $201.03 as the biotech company demonstrates strong momentum in the pharmaceutical sector.
Cannabis Tech Stocks Face Order Volatility as Market Matures
Technology providers serving cannabis operators experience heightened volatility as industry consolidation impacts equipment demand and procurement cycles.
AOC Backs Trump Cannabis Rescheduling Despite Calling It Incomplete Fix
Progressive Democrat Alexandria Ocasio-Cortez endorses Trump's marijuana rescheduling initiative while emphasizing need for comprehensive reform beyond Schedule III.
Cannabis Industry Awaits Healthcare Tech Integration Opportunities
Healthcare technology advances could reshape cannabis medical market access and patient monitoring systems across regulated markets.
AOC Backs Trump Cannabis Rescheduling Despite Social Justice Concerns
Progressive Democrat endorses federal marijuana reform while highlighting gaps in equity provisions that could impact industry legitimacy.
SNDL Reports Q1 2026 Results: Revenue Growth Amid Market Headwinds
SNDL Inc delivers mixed Q1 2026 performance with revenue gains offset by margin pressure as Canadian cannabis market consolidation continues
Cannabis Sector Transformation: Three Stocks Driving Industry Evolution
Key marijuana companies positioned to reshape sector dynamics as regulatory shifts and market maturation accelerate growth prospects.
Broader Market Volatility Pressures Cannabis Stocks Amid Oil Surge
Cannabis equities face headwinds as Dow drops on geopolitical tensions and energy price spikes, testing sector resilience in risk-off environment.
Healthcare Tech Giant Earnings Signal Medical Cannabis Opportunity
GE HealthCare's Q1 results highlight growing intersection between traditional medical technology and emerging cannabis therapeutics market.
Healthcare Automation Giant Faces Major Institutional Selloff
Investment advisor dumps $6.6M stake in medical solutions provider, signaling potential headwinds for cannabis pharmacy tech sector
WM Technology Plunges 11% as Cannabis Tech Stock Hits New Low
MAPS shares fell to $0.39 amid elevated trading volume of 2.76M shares, highlighting ongoing challenges in the cannabis technology sector.
CV Sciences Plummets 12.4% as CBD Stock Hits New Lows
CV Sciences dropped 12.4% to $0.04 amid heightened trading volume, highlighting ongoing challenges in the CBD market.
56M-Year-Old Cannabis Fossil Discovery Could Reshape Industry Narratives
Berlin museum fossil dating to 56 million years ago may be oldest known cannabis plant, potentially strengthening industry arguments about plant's natural history.
Omega Healthcare Q1 2026 Results Signal REIT Sector Strength
Healthcare REIT posts solid quarterly performance as cannabis real estate demand continues driving portfolio growth and tenant stability.
Federal Study Reveals Public Wants Full Cannabis Legalization Over Rescheduling
Government-funded research shows Americans demand comprehensive marijuana reform beyond Trump's limited rescheduling proposal, signaling political pressure ahead.
DEA Study: Public Wants Full Cannabis Legalization Beyond Rescheduling
Federal analysis of 42,913 DEA comments reveals majority support for complete marijuana reform, not just rescheduling to Schedule III.